Axial Biotech, Inc. was a privately held molecular diagnostics company based in Salt Lake City, Utah.

[2] AIS genetic testing is the process of analyzing the DNA of a patient who has been diagnosed with adolescent idiopathic scoliosis to determine his or her likelihood of progression to a severe spinal curve.

The majority of adolescents with idiopathic scoliosis are observed at regular intervals (usually between 4–6 months) with a physical exam and x-ray to evaluate the magnitude of the curve.

Approximately 85-90% of patients initially diagnosed with AIS will never have their mild scoliotic curve progress to a magnitude that requires surgical treatment.

This knowledge can make it unnecessary for these patients to undergo numerous office visits and be exposed to radiographic imaging over many years to monitor potential curve progression.